| Filed On | Filing |
|---|---|
| 05 Jul 2024 |
8-K/A: Departure/Election of Directors or Officers; Compensation
We are pleased to extend this letter of offer to you, amending your current service contract dated August 15, 2023. This amendment recognizes your role as Chief Executive Officer (CEO) and Acting Chief Financial Officer (CFO) of BioNexus... |
| 30 Oct 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Mr. Leong has a family relationship with the Company’s CFO, Wei Li Leong. Ms. Wei Li Leong is the daughter of Mr. Leong. |
| 11 Mar 2021 | 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets |
Loading...
